| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M110314200 |
| P698 | PubMed publication ID | 11786541 |
| P50 | author | Koji Uchida | Q67410444 |
| P2093 | author name string | Takahiro Shibata | |
| Makio Kobayashi | |||
| Mitsuhiro Kondo | |||
| Noriyuki Shibata | |||
| Toshihiko Osawa | |||
| P2860 | cites work | Apoptosis in the pathogenesis and treatment of disease | Q28235731 |
| 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma | Q29615221 | ||
| Nitric oxide and macrophage function | Q29615327 | ||
| A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation | Q29619212 | ||
| PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines | Q29620217 | ||
| The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
| Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity | Q33840513 | ||
| Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase | Q33886831 | ||
| Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen | Q33918180 | ||
| Biological activities and mechanisms of action of PGJ2 and related compounds: an update | Q35531399 | ||
| 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. | Q35698498 | ||
| 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma | Q36250879 | ||
| The eicosanoids and their biochemical mechanisms of action | Q38629853 | ||
| The biology and pharmacology of PGD2. | Q39638453 | ||
| Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages | Q40841282 | ||
| The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss | Q41358401 | ||
| Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin | Q41867941 | ||
| Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells | Q42464570 | ||
| Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress | Q43559588 | ||
| Effects of cyclopentenone prostaglandins and related compounds on insulin-like growth factor-I and Waf1 gene expression. | Q55477870 | ||
| 2-Cyclopenten-1-one, a New Inducer of Heat Shock Protein 70 with Antiviral Activity | Q58411519 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| 15-deoxy-Delta(12,14)-prostaglandin J2(1-) | Q27158425 | ||
| P304 | page(s) | 10459-10466 | |
| P577 | publication date | 2002-01-10 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes | |
| P478 | volume | 277 |
| Q33999923 | 15-Deoxy- γ 12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPAR γ and Reduction in NF- κ B Activity. |
| Q34063810 | 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis |
| Q40091899 | 15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. |
| Q39886791 | 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? |
| Q44195479 | 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells |
| Q64234968 | 15-Deoxy-Δ-prostaglandin J2 promotes phosphorylation of eukaryotic initiation factor 2α and activates the integrated stress response |
| Q39197422 | 15-Deoxy-Δ12,14-Prostaglandin J2 Modifies Components of the Proteasome and Inhibits Inflammatory Responses in Human Endothelial Cells |
| Q33631228 | 15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction |
| Q92861301 | 15-Deoxy-Δ12,14-prostaglandin J2 as a potential regulator of bone metabolism via PPARγ-dependent and independent pathways: a review |
| Q34477927 | 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ as an electrophilic mediator |
| Q27316915 | 15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome. |
| Q37221232 | 15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes |
| Q33652010 | 15-deoxy-Delta12,14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis. |
| Q39963327 | 15-deoxy-Delta12,14-prostaglandin J2 impairs phosphatidylcholine synthesis and induces nuclear accumulation of thiol-modified cytidylyltransferase |
| Q44353642 | 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells |
| Q64052521 | 15-deoxy-Δ12,14-Prostaglandin J2 inhibits human soluble epoxide hydrolase by a dual orthosteric and allosteric mechanism |
| Q39021000 | 15-deoxy-Δ12,14-prostaglandin J₂ induces p53 expression through Nrf2-mediated upregulation of heme oxygenase-1 in human breast cancer cells |
| Q39008479 | 15-deoxy-Δ¹²,¹⁴-PGJ₂ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis |
| Q40810593 | 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis |
| Q28288854 | 9alpha,11beta-PGF2 and its stereoisomer PGF2alpha are novel agonists of the chemoattractant receptor, CRTH2 |
| Q55669624 | A Snake Venom-Secreted Phospholipase A2 Induces Foam Cell Formation Depending on the Activation of Factors Involved in Lipid Homeostasis. |
| Q35190764 | A novel PGD(2) receptor expressed in eosinophils |
| Q40540399 | A novel antipyretic action of 15-deoxy-Delta12,14-prostaglandin J2 in the rat brain. |
| Q41827352 | Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction |
| Q35222158 | Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes |
| Q44880248 | Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice |
| Q35573256 | Activation of nuclear receptors by prostaglandins |
| Q38800299 | Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death |
| Q44417208 | Activation-induced PPARγ expression sensitizes primary human T cells toward apoptosis |
| Q34350918 | Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. |
| Q24299872 | Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis |
| Q34016727 | Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism |
| Q33727905 | Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer |
| Q40461294 | Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. |
| Q36836542 | Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions. |
| Q34717638 | Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. |
| Q34931955 | Anti-inflammatory lipid mediators and insights into the resolution of inflammation |
| Q44904582 | Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans |
| Q44349204 | Biosynthesis of 14,15-dehydro-12-oxo-phytodienoic acid and related cyclopentenones via the phytoprostane D(1) pathway |
| Q35919761 | Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma |
| Q36283503 | COX-2 and prostaglandins in atherosclerosis. |
| Q36760539 | COX-2 and the vasculature: angel or evil? |
| Q42007327 | CXCR4 in Cancer and Its Regulation by PPARgamma |
| Q40616566 | Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products |
| Q33604169 | Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock |
| Q36012280 | Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2 |
| Q34505806 | Chemoattractant receptor homologous to the T helper 2 cell (CRTH2) is not expressed in human amniocytes and myocytes |
| Q48237663 | Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells |
| Q28472176 | Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia |
| Q36954499 | Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. |
| Q90093917 | Crth2 receptor signaling down-regulates lipopolysaccharide-induced NF-κB activation in murine macrophages via changes in intracellular calcium |
| Q42817241 | Cultured preadipocytes undergoing stable transfection with cyclooxygenase-1 in the antisense direction accelerate adipogenesis during the maturation phase of adipocytes |
| Q33356788 | Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. |
| Q38111723 | Cyclooxygenase metabolites in the kidney |
| Q34452830 | Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice |
| Q73438403 | Cyclooxygenase-2 inhibitors and atherosclerosis |
| Q33859389 | Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. |
| Q41595305 | Decreased Prostaglandin D2 Levels in Major Depressive Disorder Are Associated with Depression-Like Behaviors |
| Q34634623 | Dexamethasone protects neonatal hypoxic-ischemic brain injury via L-PGDS-dependent PGD2-DP1-pERK signaling pathway. |
| Q28252919 | Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells |
| Q58801536 | Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease |
| Q51042965 | Early increase in alveolar macrophage prostaglandin 15d-PGJ2 precedes neutrophil recruitment into lungs of cytokine-insufflated rats. |
| Q40691219 | Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase |
| Q34931884 | Emerging roles of PPARs in inflammation and immunity |
| Q91751003 | Enantioselective Synthesis of 15-Deoxy-Δ12,14-Prostaglandin J2 |
| Q40200021 | Endogenous 15-deoxy-Delta(12,14)-prostaglandin J(2) synthesized by adipocytes during maturation phase contributes to upregulation of fat storage |
| Q28195805 | Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor |
| Q35873155 | Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. |
| Q44892162 | Fatty acid-mediated inhibition of IL-12 production by murine macrophages is independent of PPARgamma |
| Q39385137 | Generation of monoclonal antibody for 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ and development of enzyme-linked immunosorbent assay for its quantification in culture medium of adipocytes |
| Q54421712 | Genes for prostaglandin synthesis, transport and inactivation are differentially expressed in human uterine tissues, and the prostaglandin F synthase AKR1B1 is induced in myometrial cells by inflammatory cytokines. |
| Q41889468 | Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis |
| Q47723266 | Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts |
| Q40141303 | IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. |
| Q58603870 | Identification and Molecular Characterization of PPARδ as a Novel Target for Covalent Modification by 15-deoxy-Δ-prostaglandin J |
| Q42828985 | Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation. |
| Q38478069 | Identification of a prostaglandin D2 metabolite as a neuritogenesis enhancer targeting the TRPV1 ion channel |
| Q37254482 | Immune mechanisms in thyroid eye disease. |
| Q37867910 | Immunochemical detection of food-derived polyphenols in the aorta: macrophages as a major target underlying the anti-atherosclerotic activity of polyphenols |
| Q36954995 | Increased generation of cyclopentenone prostaglandins after brain ischemia and their role in aggregation of ubiquitinated proteins in neurons |
| Q39458129 | Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGD₂ metabolite, 15d-PGJ₂. |
| Q42334005 | Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment |
| Q43161105 | Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. |
| Q40626344 | Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase |
| Q46875223 | Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species |
| Q51780757 | Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro. |
| Q35174731 | Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases |
| Q35332267 | Isoprostane generation and function |
| Q39113995 | Isotope-dilution UPLC-MS/MS determination of cell-secreted bioactive lipids |
| Q52917513 | Localization of 14-3-3δ/ξ on the neuronal cell surface. |
| Q42806486 | Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2. |
| Q34449816 | Mechanisms of fever production and lysis: lessons from experimental LPS fever |
| Q36796254 | Methods for determining the modification of protein thiols by reactive lipids. |
| Q34814329 | Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. |
| Q38118666 | Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function |
| Q62395115 | Modification of lipids by reactive oxygen and nitrogen species: the oxy–nitroxy–lipidome and its role in redox cell signaling |
| Q41598067 | Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. |
| Q35058868 | Molecular biological approaches to neurological disorders including knockout and transgenic mouse models |
| Q40685661 | Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. |
| Q34933261 | Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration |
| Q34395104 | Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo |
| Q35673358 | Novel Therapeutic Agents in Pediatric Sepsis: Peroxisome Proliferator Receptor γ (PPAR γ) Agonists |
| Q39986624 | Oxidative stress-inducible lentiviral vectors for gene therapy. |
| Q34913467 | PPAR and immune system--what do we know? |
| Q43974270 | PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. |
| Q41763780 | PPARs and lipid ligands in inflammation and metabolism |
| Q42210954 | Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation |
| Q44688340 | Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism |
| Q45964694 | Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. |
| Q35128478 | Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation |
| Q39181325 | Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases |
| Q44893449 | Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats |
| Q35597447 | Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease |
| Q39236149 | Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells. |
| Q42797761 | Prostaglandin D2 and J2-series (PGJ2, Delta12-PGJ2) prostaglandins stimulate IL-6 and MCP-1, but inhibit leptin, expression and secretion by 3T3-L1 adipocytes |
| Q37524364 | Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites |
| Q40273360 | Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells |
| Q46926278 | Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress |
| Q34179727 | Prostaglandins and inflammation |
| Q44814173 | Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures |
| Q39849130 | Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells |
| Q33308185 | Protein damage by reactive electrophiles: targets and consequences |
| Q26824737 | Protein lipoxidation: Detection strategies and challenges |
| Q39162650 | Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2. |
| Q35078149 | Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog. |
| Q35978080 | Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2. |
| Q33885097 | Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function |
| Q28386488 | Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acids |
| Q37114625 | Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation |
| Q26747410 | Resolution of Inflammation: What Controls Its Onset? |
| Q90886252 | Resolution of inflammation and mood disorders |
| Q38078228 | Resolution of inflammation as a novel chemopreventive strategy |
| Q34191947 | Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin |
| Q45305148 | Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. |
| Q44591151 | Role of PPARgamma in inflammatory response related to mast cells |
| Q46260464 | Sensitive mass spectrometric assay for determination of 15-deoxy-Δ(12,14)-prostaglandin J2 and its application in human plasma samples of patients with diabetes |
| Q42801681 | Specific Gene Expression of Isoforms in Cyclooxygenase Pathway to Generate PGJ2 Derivatives during the Differentiation of 3T3-L1 Adipocytes |
| Q42803031 | Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids |
| Q44512407 | Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis |
| Q41955640 | Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice |
| Q64119901 | Sustained exposure to prostaglandin D augments the contraction induced by acetylcholine via a DP receptor-mediated activation of p38 in bronchial smooth muscle of naive mice |
| Q41779175 | Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia |
| Q89476824 | The Anti-Neuron-Specific Enolase Antibody Induced Neuronal Cell Death in a Novel Fashion |
| Q40144707 | The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages |
| Q45272329 | The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. |
| Q34189442 | The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras |
| Q28533399 | The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism |
| Q27021651 | The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity |
| Q36349945 | The point mutation UCH-L1 C152A protects primary neurons against cyclopentenone prostaglandin-induced cytotoxicity: implications for post-ischemic neuronal injury |
| Q80514875 | The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury |
| Q36617121 | The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. |
| Q40606502 | The role of aldo-keto reductase 1C3 (AKR1C3)-mediated prostaglandin D2 (PGD2) metabolism in keloids |
| Q28271189 | The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis |
| Q35792099 | Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes |
| Q50852528 | Total Synthesis of Δ(12) -Prostaglandin J3 : Evolution of Synthetic Strategies to a Streamlined Process. |
| Q34550467 | Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2) |
| Q37078390 | UVB light upregulates prostaglandin synthases and prostaglandin receptors in mouse keratinocytes |
| Q34632798 | Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice |
Search more.